RA Capital Management, L.P. 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-10 4:33 pm Purchase |
2025-03-06 | 13D | Janux Therapeutics, Inc. JANX |
RA Capital Management, L.P. | 11,971,377 19.900% |
1,528,196 (+14.63%) |
Filing |
| 2024-10-22 4:17 pm Sale |
2024-10-18 | 13D | Janux Therapeutics, Inc. JANX |
RA Capital Management, L.P. | 10,443,181 19.990% |
-299,812 (-2.79%) |
Filing |
| 2024-09-16 9:35 pm Purchase |
2024-09-12 | 13D | Janux Therapeutics, Inc. JANX |
RA Capital Management, L.P. | 10,742,993 19.990% |
149,598 (+1.41%) |
Filing |
| 2024-03-06 6:54 pm Purchase |
2024-03-04 | 13D | Janux Therapeutics, Inc. JANX |
RA Capital Management, L.P. | 10,593,395 19.990% |
1,922,751 (+22.18%) |
Filing |
| 2021-06-16 5:20 pm Purchase |
2021-06-15 | 13D | Janux Therapeutics, Inc. JANX |
RA Capital Management, L.P. | 8,670,644 20.800% |
8,670,644 (New Position) |
Filing |